Pri-Med | PrimaryCareNOW: A Pri-Med Virtual...

Thank you to all who joined us live for PrimaryCareNOW on Thursday–Friday, October 15–16, 2020. If you were not able to join us, most sessions have been recorded and are available below.

Upcoming Virtual Conferences
Pri-Med has more virtual education planned. View our upcoming virtual conference schedule.

Upcoming Conferences

Agenda

CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

Thursday, October 15
Friday, October 16

8–9am ET

Infectious Disease

Managing Influenza: Practical Strategies For Primary Care

Pamela Kushner, MD, FAAFP | Paul E. Sax, MD

On Demand

Is influenza going viral in your practice? This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.

Pamela Kushner, MD, FAAFP

Clinical Professor, University of California Irvine Medical Center, Director, Kushner Wellness Center, Los Alamitos, CA

Paul E. Sax, MD

Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA

Supported by Genentech

9:10–10:10am ET

Endocrinology

Improving Patient Outcomes in T2DM: GLP‐1 Receptor Agonists Benefits in Addition to Improved Glucose Control

Rachel M. Foster (Patient) | Tina K. Thethi, MD, MPH, FACE | Charles Vega, MD, FAAFP

On Demand

Over ten percent of the U.S. population suffers disproportionate cardiometabolic risk because of their type 2 diabetes (T2DM). In light of recent data, GLP-1 receptor agonists (GLP-1 RAs) have taken on a more prominent role in T2DM management algorithms. This session will discuss how you can distinguish among GLP-1 RAs and use them in your practice to help manage the risks that these patients face beyond glucose control. A member of the Diabetes Sisters organization will also be joining us to discuss their experience with starting a GLP-1 RA as a patient.

Rachel M. Foster (Patient)

DiabetesSisters, Saint Paul, MN

Tina K. Thethi, MD, MPH, FACE

Associate Investigator and Endocrinologist, Translational Research Institute, AdventHealth, Orlando, FL

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

Supported by Novo Nordisk Inc.

10:20–11:05am ET

Industry Theater

Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain

Dr. Jason Faller

1.) Understand the causes and prevalence of chronic low back pain
2.) Differentiate inflammatory back pain (IBP) from mechanical back pain
3.) Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS)
4.) Learn the importance of referring patients with IBP to a rheumatologist in a timely manner

Dr. Jason Faller

11:15am–12:15pm ET

Neurology

Alzheimer’s Disease in Primary Care: Gaining Diagnostic & Management Confidence in a Changing Clinical Landscape

Liana G. Apostolova, MD, MSc, FAAN | Gad A. Marshall, MD

On Demand

It is important to recognize and address cognitive complaints and dementia symptoms early in the disease continuum and as part of routine care. Steps to diagnose mild cognitive impairment and Alzheimer’s disease will be discussed, as will the importance of early treatment. Approaches to Alzheimer’s disease prevention, including lifestyle changes, will be presented, along with emerging disease-modifying therapies.

Liana G. Apostolova, MD, MSc, FAAN

Barbara and Peer Baekgaard Professor in Alzheimer's Disease Research, Professor in Neurology, Radiology, Medical and Molecular Genetics, Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana

Gad A. Marshall, MD

Associate Professor of Neurology, Harvard Medical School, Associate Medical Director of Clinical Trials, Center for Alzheimer Research & Treatment, Brigham and Women's Hospital, Massachusetts General Hospital, Boston, Massachusetts

Supported by Biogen Inc.

12:25–1:25pm ET

Infectious Disease

Case Challenges in Infectious Disease: STD, Hepatitis, and Adult Vaccinations

Hana El Sahly, MD

On Demand

This session will approach three challenging areas of infectious disease that the primary care clinician faces on a regular basis: sexually transmitted infections, vaccination, and hepatitis. In the past few years, there has been a tremendous rise in the incidence of sexually transmitted infections. Faculty will update the audience on recent developments in the management of patients with sexually transmitted infections. Also continually updated, are the guidelines on adult vaccination. This session will provide updates on the adult vaccination schedule. Lastly, faculty will discuss the epidemiology of viral hepatitis.

Hana El Sahly, MD

Associate Professor, Departments of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, TX

1:35–2:20pm ET

Industry Theater

Influenza Vaccination Strategies to Help Protect Older Adults Before “Flu Season” Hits

John J. Russell, MD, FAAFP

• Examine the medical burden of influenza and its economic impact in adults 50+ years of age
• Explore how influenza can exacerbate chronic health conditions and lead to adverse outcomes
• Review clinical evidence of 2 influenza vaccines that were compared to standard-dose influenza vaccines in older adults

John J. Russell, MD, FAAFP

Director, Family Medicine Residency Program, Abington Memorial Hospital, Clinical Professor, Family and Community Medicine, Sidney Kimmel Medical College, Philadelphia, Pennsylvania

1:35–2:20pm ET

Industry Theater

Making an Impact: The Implications of Optimizing Heart Failure Care and Delivering Value-based Care

Nihar R. Desai, MD, MPH

On Demand

A disease state educational presentation reviewing the epidemiology and clinical course of heart failure, including the identification of signs and symptoms of worsening heart failure. The presentation discusses management of heart failure care surrounding hospitalization, and the interplay between optimizing heart failure care and quality and performance measures. Dr. Desai shares some practical insights to optimizing heart failure management and delivering value-based care.

Nihar R. Desai, MD, MPH

Yale School of Medicine, Section of Cardiovascular Medicine, Center for Outcomes Research and Evaluation, New Haven, CT

Sponsored by Novartis Pharmaceuticals Corporation

2:30–4pm ET

Geriatrics

Geriatric Update: Cognitive Decline and Polypharmacy

Sara M. Bradley, MD, FACP | Lee A. Lindquist, MD, MPH, MBA

On Demand

As we see more patients with cognitive impairment, understanding the real-world care for this population is vital. This lecture will review the most efficient means of assessing cognitive impairment, examine common issues in caring for the older adult with cognitive impairment, and discuss pharmacologic/non-pharmacologic means of treating patients. Dr. Lindquist will also address updates on what medications are useless/useful and what testing should be avoided.

Polypharmacy is common among older adults and associated with adverse outcomes. This case-based session will review how to avoid inappropriate prescribing, recognize adverse drug events, and identify opportunities to deprescribe. Dr. Bradley will review recent literature updates that inform our prescribing practices including the 2019 AGS Beers criteria. Tips to enhance safe medication use will be shared.

The updates will be followed by an “Ask the Expert” session with Drs. Lindquist and Bradley where they will review common questions and take questions from attendees.

Sara M. Bradley, MD, FACP

Associate Professor, Northwestern University Feinberg School of Medicine, Division of General Internal Medicine and Geriatrics, Chicago, IL

Lee A. Lindquist, MD, MPH, MBA

Associate Professor of Medicine, Section Chief of Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL

4:10–5:10pm ET

Hot Topic

Panel Discussion: Cases and Controversies in Vaping and Medical Marijuana

Farrah Kheradmand, MD, MS | Marc Robinson, MD

On Demand

Cannabis use continues to rise in the United States, driven by expansion of laws legalizing recreational and medical use. With this increased use comes an increase in side effects, such as lung injuries from vaping and a rise in cannabis use disorder. Faculty will discuss what practitioners should know about vaping and cannabis use, and what they should tell their patients. This session will also inform the attendees of the most recent clinical and radiographic findings in patients diagnosed with e-cigarette and vaping associated acute lung injury.

Farrah Kheradmand, MD, MS

Professor of Medicine, Pathology and Immunology and Staff Physcician, Houston VA

Marc Robinson, MD

Assistant Professor, Baylor College of Medicine, Houston, TX

5:20–6:05pm ET

Industry Theater

Personalizing Inhaled Therapy and Inhaler Choice for COPD Management

Samuel Louie, M. D.

Early and accurate diagnosis of chronic obstructive pulmonary disease (COPD) followed by optimal management are very important. This educational activity, will discuss the diagnosis of COPD, goals for treatment, pharmacological management, and the role of inhaled therapy and inhaler choice in the management of patients with COPD.

Samuel Louie, M. D.

Professor of Medicine, University of California, Davis Health

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

5:20–6:05pm ET

Industry Theater

Role of the Kidney in Glucose Regulation in Type 2 Diabetes

JP Frias, MD

On Demand

•Review the pathophysiology of T2DM that contributes to hyperglycemia
•Understand the role of the kidney in glucose regulation
•Review a treatment option for adults with T2DM

JP Frias, MD

8–9am ET

Keynote Address

Clinical Genomics for Precision Medicine

Richard A. Gibbs, AC, PhD

On Demand

This talk will cover the potential and the challenges in genetic discovery that need to be met in order to support the utility of genomics in clinical care. Genome methods including whole genome sequencing will be covered. The successes in pediatric genetics will be contrasted with the greater challenges in adult medicine.

Richard A. Gibbs, AC, PhD

Founding Director, Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX

9:10–10:10am ET

Neurology

A Head Start on Migraine: Emerging Approaches to Acute Management

Rashmi B. Halker Singh, MD, FAHS, FAAN | Pamela Kushner, MD, FAAFP

On Demand

With the latest on new and emerging approaches treatment and the most up-to-date patient-centered strategies, this talk will give you a head start on managing acute migraine. Faculty will illustrate the features of acute migraine to help you distinguish it from other headache types and use interactive patient cases to impart practice-changing takeaways about patient management.

Rashmi B. Halker Singh, MD, FAHS, FAAN

Headache Fellowship Program Director, Associate Professor of Neurology, Mayo Clinic, Scottsdale, AZ

Pamela Kushner, MD, FAAFP

Clinical Professor, University of California Irvine Medical Center, Director, Kushner Wellness Center, Los Alamitos, CA

Supported by Allergan

10:20–11:05am ET

Industry Theater

Management of Osteoarthritis and Chronic Pain: Where Are We Now?

Tracey Mallick-Searle, RN-BC, ANP-BC | Steven P. Stanos, DO, FABPM

On Demand

This presentation will provide an overview of the epidemiology and treatment of osteoarthritis (OA) and chronic OA pain. We will review the current understanding of chronic pain pathophysiology – the various mediators, their role in central and peripheral sensitization, and the nociceptive components of chronic OA pain. We will also examine current OA treatment guidelines and explore “multimodal” treatment options, with a focus on working with patients toward individual treatment goals, and the establishment of holistic management strategies for patients with chronic OA pain.

Tracey Mallick-Searle, RN-BC, ANP-BC

Division of Pain Medicine, Stanford Health Care, Redwood City, CA

Steven P. Stanos, DO, FABPM

Swedish Health System Pain Medicine and Services, Seattle, WA

Sponsored by Pfizer and Eli Lilly and Company

11:15am–12:15pm ET

Pulmonology

Updates on Asthma and COPD

Sunjay Devarajan, MD

On Demand

Asthma & chronic obstructive pulmonary disease (COPD) can have overlapping symptoms, but they are characterized by different pathogenic mechanisms and different responses to anti-inflammatory therapies. Dozens of medications and interventions have been approved and prescribed to combat these diseases, and treatments strategies have been developed that depend largely on severity of symptoms. But how should we approach these patients? What’s new in asthma and COPD? This case-based presentation will help you review what you need to know about asthma and COPD in 2020.

Sunjay Devarajan, MD

Assistant Professor in Pulmonary/Critical Care, Baylor College of Medicine, Houston, TX

12:25–1:25pm ET

Endocrinology

Traversing the Chasm: Overcoming Challenges of Obesity Management in Primary Care

Scott Kahan, MD, MPH, FTOS, DABOM | Michelle Look, MD, FAAFP, DABOM

On Demand

This activity will feature virtual patient videos to model communication techniques to improve patient-provider communication. Evidence-based approaches to individualized obesity treatment plans, including weight loss pharmacotherapy, addressing and overcoming barriers for weight-loss, and current guidelines will also be discussed.

Scott Kahan, MD, MPH, FTOS, DABOM

Director, National Center for Weight and Wellness; Faculty, Johns Hopkins Bloomberg School of Public Health

Michelle Look, MD, FAAFP, DABOM

Family Practice - Sports Medicine, Obesity Medicine, San Diego Sports Medicine and Family Health Center, San Diego, CA

Supported by Novo Nordisk Inc.

1:35–2:20pm ET

Industry Theater

Chronic Obstructive Pulmonary Disease (COPD): How to Approach the Recently Diagnosed Patient

Michael Campos, MD

As there are many factors that can contribute to the occurrence of COPD, this presentation will discuss the differential diagnosis of COPD, as well as provide recommendations for evaluating these patients for underlying conditions.

Michael Campos, MD

Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Miami

1:35–2:20pm ET

Industry Theater

Know When Eosinophils Play a Role in Severe Asthma

Nicola Hanania, MD, MS

Join us for an educational program exploring the role of eosinophils in severe asthma. This presentation will examine key concepts in severe asthma, including, defining severe uncontrolled asthma and the impact of oral corticosteroid (OCS) use in severe uncontrolled asthma.

Nicola Hanania, MD, MS

Associate Professor, Pulmonary Medicine, Director, Airways Clinical Research Center, Baylor College of Medicine, Houston TX

2:30–3:30pm ET

Oncology

Updates on Cancer Screening

Daniel Y. Wang, MD

On Demand

The early detection of cancer can significantly improve the treatment and outcomes for patients. Screening is an effective tool for early detection, but emerging evidence constantly shift these recommendations. This case-based presentation will focus on the most recent guidelines from the leading agencies including ACS, NCCN, and USPSTF and discuss strategies on how to apply them to your patients.

Daniel Y. Wang, MD

Assistant Professor in Medicine, Section of Hematology/Oncology, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX

3:40–4:10pm ET

Infectious Disease

COVID-19: Ask the ID Expert

Pamela Kushner, MD, FAAFP | Paul E. Sax, MD

On Demand

These troubling times require communication among specialists and primary care. In this COVID-19 ask the expert, faculty will discuss the most pressing and frequently asked questions about this disease and its complications.

Pamela Kushner, MD, FAAFP

Clinical Professor, University of California Irvine Medical Center, Director, Kushner Wellness Center, Los Alamitos, CA

Paul E. Sax, MD

Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School, Boston, MA

4:20–5:20pm ET

Hot Topic

Tackling Tough Ethical Cases in the Clinic

Joslyn Fisher, MD, MPH

On Demand

While outpatient ethics training is relatively scant, many primary care clinicians encounter challenging situations in clinic that raise ethical considerations—and the pandemic has brought several important ethical questions and dilemmas to the forefront. This case-based discussion will review strategies for managing these moral dilemmas in the age of COVID-19.

Joslyn Fisher, MD, MPH

Associate Professor of Medicine & Medical Ethics, Baylor College of Medicine, Houston, TX

5:30–6:15pm ET

Industry Theater

Case Study: Progressive Muscle Weakness in a 28-Year-Old Female and a Treatment for the Disease

Lamar Davis, MD

Participants are invited to join us in an interactive discussion to uncover the cause of the patient's symptoms and work together on this complex case. A treatment will be discussed following the diagnosis.

Lamar Davis, MD

Associate Professor, Pediatrics and Neurology, University of Mississippi Medical Center, Jackson, MS.

5:30–6:15pm ET

Industry Theater

Acute Exacerbations: Predictors of Poor Outcomes in COPD

Donald A. Mahler, MD

On Demand

This program will examine the risk factors associated with COPD exacerbations and the potential impacts of acute exacerbations on patient health, quality of life, and mortality. An understanding of COPD exacerbations and the range of consequences highlights opportunities to optimize COPD management earlier in the course of disease.